Jacobs Levy Equity Management’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-62,225
| Closed | -$732K | – | 1052 |
|
|
2019
Q2 | $732K | Sell |
62,225
-23,400
| -27% | -$275K | 0.01% | 688 |
|
|
2019
Q1 | $1.17M | Buy |
85,625
+40,100
| +88% | +$547K | 0.02% | 626 |
|
|
2018
Q4 | $467K | Buy |
45,525
+20,900
| +85% | +$214K | 0.01% | 743 |
|
|
2018
Q3 | $410K | Buy |
24,625
+10,925
| +80% | +$182K | 0.01% | 818 |
|
|
2018
Q2 | $216K | Buy |
+13,700
| New | +$216K | ﹤0.01% | 942 |
|
|
2018
Q1 | – | Sell |
-33,080
| Closed | -$379K | – | 1110 |
|
|
2017
Q4 | $379K | Buy |
+33,080
| New | +$379K | 0.01% | 802 |
|